SOPH
Sophia Genetics SANASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$379.13M
P/E Ratio
—
EPS
$-1.17
Beta
1.01
52W High
$5.70
52W Low
$2.59
50-Day MA
$4.83
200-Day MA
$4.41
Dividend Yield
—
Profit Margin
-102.20%
Forward P/E
—
PEG Ratio
—
About Sophia Genetics SA
Sophia Genetics SA (SOPH) is a trailblazer in data-driven medicine, specializing in advanced genomic and clinical data analytics aimed at improving patient outcomes. Leveraging state-of-the-art machine learning algorithms, the company offers a robust platform that empowers hospitals and laboratories to decode complex genomic information, thereby enabling personalized treatment approaches, particularly in oncology, rare diseases, and hereditary conditions. With a strong global presence and strategic alliances with leading healthcare institutions, Sophia Genetics is dedicated to revolutionizing healthcare through precision medicine, reinforcing its status as a key player in the genomics sector.
Fundamentals
| Revenue (TTM) | $77.27M |
| Gross Profit (TTM) | $52.08M |
| EBITDA | $-69.17M |
| Operating Margin | -85.40% |
| Return on Equity | -110.00% |
| Return on Assets | -27.90% |
| Revenue/Share (TTM) | $1.14 |
| Book Value | $0.69 |
| Price-to-Book | 8.09 |
| Price-to-Sales (TTM) | 4.91 |
| EV/Revenue | 4.84 |
| EV/EBITDA | -0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 22.40% |
| Shares Outstanding | $71.67M |
| Float | $51.58M |
| % Insiders | 8.36% |
| % Institutions | 48.42% |
Historical Volatility
HV 10-Day
44.83%
HV 20-Day
38.62%
HV 30-Day
43.81%
HV 60-Day
45.82%
HV Rank
4.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.00 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026